CVS Health CVS
$83.85 +$2.52 (+3.10%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $84.15 +0.36%
Open$80.70
Prev close$81.33
Day range$80.69 – $84.38
Volume16.10M
Market cap$107.28B
P/E (TTM)9.7
Dividend yield3.17%
Earnings
Average move on report day±5.1%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+14.9%
Worst reaction-16.8%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | Pre Market | ±5.6% | -5.08% | Within range |
| 2026/Q1 | 6 May 2026 | Pre Market | ±5.8% | +7.65% | Bigger than priced |
| 2025/Q4 | 10 Feb 2026 | Pre Market | ±5.5% | -0.09% | Within range |
| 2025/Q3 | 29 Oct 2025 | Pre Market | ±4.9% | -1.95% | Within range |
| 2025/Q2 | 31 Jul 2025 | Pre Market | ±7.8% | -0.32% | Within range |
| 2025/Q1 | 1 May 2025 | None | ±6.2% | +4.11% | Within range |
| 2024/Q4 | 12 Feb 2025 | Pre Market | ±8.3% | +14.95% | Bigger than priced |
| 2024/Q3 | 6 Nov 2024 | Pre Market | ±8.1% | +11.33% | Bigger than priced |
| 2024/Q2 | 7 Aug 2024 | Pre Market | ±8.2% | -3.21% | Within range |
| 2024/Q1 | 1 May 2024 | Pre Market | ±4.8% | -16.84% | Bigger than priced |
| 2023/Q4 | 7 Feb 2024 | Pre Market | ±4.7% | +3.10% | Within range |
| 2023/Q3 | 1 Nov 2023 | Pre Market | ±4.9% | -0.41% | Within range |
| 2023/Q2 | 2 Aug 2023 | Pre Market | ±4.7% | +3.33% | Within range |
| 2023/Q1 | 3 May 2023 | Pre Market | ±4.7% | -3.68% | Within range |
| 2022/Q4 | 8 Feb 2023 | Pre Market | ±3.9% | +3.47% | Within range |
| 2022/Q3 | 2 Nov 2022 | Pre Market | ±4.5% | +2.30% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q2
By business line
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$106.10B+7.3% YoY
Operating profit$4.70B+97.5% YoY
Net profit$3.00B+195.7% YoY
Diluted EPS$2.31+188.8% YoY
Free cash flow$5.65B+338.3% YoY
Operating cash flow$6.35B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin14.2%
Operating margin3.4%
Net margin1.2%
Return on equity6.2%
Return on assets1.9%
Return on invested capital4.8%
Current ratio0.87
Liabilities / assets68.5%
Cash & investments$13.96B
Total debt$74.39B
Net cash (debt)-$60.43B
Free cash flow / sales2.8%
No comments yet — be the first to weigh in on CVS.
Sign in to join the discussion.